Population pharmacokinetics of Daunorubicin in adult patients with acute myeloid leukemia

PURPOSE: Chemotherapy drug resistance and relapse of the disease have been the major factors limiting the success of acute myeloid leukemia (AML) therapy. Several factors, including the pharmacokinetics (PK) of Cytarabine (Ara-C) and Daunorubicin (Dnr), could contribute to difference in treatment ou...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Chemother Pharmacol
Autors principals: Varatharajan, Savitha, Panetta, John C., Abraham, Ajay, Karathedath, Sreeja, Mohanan, Ezhilpavai, Lakshmi, Kavitha M., Arthur, Nancy, Srivastava, Vivi M., Nemani, Sandeep, George, Biju, Srivastava, Alok, Mathews, Vikram, Balasubramanian, Poonkuzhali
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7115946/
https://ncbi.nlm.nih.gov/pubmed/27738808
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-016-3166-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars